Background TNF-like weak inducer of apoptosis (TWEAK) is a proinflammatory molecule that plays a key role in active inflammation of lupus nephritis (LN). Urine TWEAK (uTWEAK) levels were found to be associated with renal disease activity among patients with LN. Here. we determined whether serial measurements of uTWEAK during induction therapy could predict treatment response or not. https://darthomes.shop/product-category/tape-dispensers/